Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 12 May 2023
According to a recent study, using AI reduced the amount of time radiologists needed to read chest x-rays, increasing their effectiveness.
Read Full NewsThe World Health Organization on Thursday declared the hantavirus outbreak linked to a cruise ship over after the last identified contact of an exposed person completed...
New South Wales became Australia's third state to confirm a case of H5N1 bird flu after authorities said a migratory seabird found near a coastal town returned a positive...
The $500 million seed fund will support universal antiviral platforms and air cleaning technologies.
New study finds nearly 10% of internal medicine residents report a disability; the American Medical Association updates maternity care billing codes; and Texas joins autism trial network.
A UK trial finds that low-dose atropine modestly slows childhood myopia progression and axial eye growth over 2 years without increasing adverse events.
A phase 3 trial compares first-line fixed-duration venetoclax-obinutuzumab to fludarabine, cyclophosphamide, and rituximab/bendamustine-rituximab in patients with CLL.
Bepirovirsen reduced posttreatment markers of hepatitis B infection at 72 weeks, with 20% of recipients achieving functional cure vs none given placebo.
1.
Study suggests radiation therapy benefits misjudged when clinical factors alone guide breast cancer treatment
2.
MRD-Guided Azacitidine May Delay Relapse in AML, MDS
3.
Report suggests a big improvement in lung cancer survival
4.
Breast cancer screening in women's 40s can save lives, study says
5.
The use of biomarkers in the treatment of breast lumps is at a crossroads.
1.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
2.
Advanced Practices in Hematology in Daily Practice
3.
Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment
4.
A Closer Look at the Effects of Sickle Cell on Eyesight
5.
Exploring the Latest Treatments for Essential Thrombocythemia
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
2.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
3.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
5.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge